US Neurovascular Intervention Market Size, Share, Opportunities, And Trends By Specialty Type (Neurology, Neurosurgery, Neuroradiology), By Product Type (Wires & Coils, Catheters, Balloons, Stents, Others), By Disease Type (Arteriovenous Malformation, Arteriovenous Fistula, Brain Aneurysm, Others), And By End-Users (Hospitals, Ambulatory Surgical Centers) – Forecasts From 2025 To 2030

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations

3.7. Strategic Recommendations

4. US NEUROVASCULAR INTERVENTION MARKET BY SPECIALTY TYPE

4.1. Introduction

4.2. Neurology

4.3. Neurosurgery

4.4. Neuroradiology

5. US NEUROVASCULAR INTERVENTION MARKET BY PRODUCT TYPE

5.1. Introduction

5.2. Wires & Coils

5.3. Catheters

5.4. Balloons

5.5. Stents

5.6. Others

6. US NEUROVASCULAR INTERVENTION MARKET BY DISEASE TYPE

6.1. Introduction

6.2. Arteriovenous Malformation

6.3. Arteriovenous Fistula

6.4. Brain Aneurysm

6.5. Others

7. US NEUROVASCULAR INTERVENTION MARKET BY END-USERS

7.1. Introduction

7.2. Hospital

7.3. Ambulatory Surgical Centers

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

8.1. Major Players and Strategy Analysis

8.2. Emerging Players and Market Lucrativeness

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Competitive Dashboard

9. COMPANY PROFILES

9.1. Medtronic plc

9.2. Stryker Corporation

9.3. Johnson & Johnson Services, Inc.

9.4. Penumbra, Inc.

9.5. MicroVention, Inc. (Terumo Corporation)

9.6. InspireMD, Inc.

9.7. NeuroVasc Technologies, Inc.

9.8. Imperative Care, Inc.